therapy [ftcn]
Effectiveness [qlco]
coronary heart disease [dsyn]
Patients [podg]
Late period [fndg]
post surgery [tmco]
Bypass [topp]
coronary heart disease [dsyn]
Patients [podg]
Complete [qlco]
Myocardial Revascularization [topp]
Effectiveness [qlco]
therapy [ftcn]
Aspirin [orch, phsu]
thienopyridines [orch, phsu]
Cell [cell]
Haemostasis [ortf]
Parameters [fndg]
Evaluated [ftcn]
First [qnco]
Post-intervention [inpr]
Platelet aggregation [celf]
Assessed [acty]
Turbidimetry [lbpr]
Method [inpr]
Using [ftcn]
ADP [lbpr]
DI [gngm]
Na-Sal [orch, phsu]
Treatment Effectiveness [qlco]
Assessed [acty]
End Point [qlco]
Death [orgf]
Myocardial Infarction [dsyn]
Recurrent [tmco]
Angina [sosy]
RE [idcn]
intervention [hlca]
statistical analysis [resa]
Performed [ftcn]
Excel [phsu]
Program [cnce]
Stable [qlco]
Inhibition [menp]
Platelet Function [lbpr]
thienopyridine [orch, phsu]
treatment [ftcn]
low platelet [fndg]
Junctional [spco]
activity [dora]
Associated [qlco]
Reduced [qlco]
Risk [qlco]
adverse events [fndg]
coronary heart disease [dsyn]
Patients [podg]
Bypass Surgery [topp]
Aspirin [orch, phsu]
Sensitive [ftcn]
thienopyridine [orch, phsu]
Group [idcn]
P NOS [aapp, imft]
Adverse event [fndg]
Risk [qlco]
Increased [qnco]
Late period [fndg]
Post-intervention [inpr]
Patients [podg]
Aggregation [ftcn]
Cell [cell]
Haemostasis [ortf]
Received [qlco]
Aspirin [orch, phsu]
Aspirin [orch, phsu]
effective [qlco]
Secondary Prevention [topp]
Bypass Surgery [topp]
Routine [qlco]
Administration [ocac]
Not [ftcn]
Recommended [idcn]
Cell [cell]
Haemostasis [ortf]
Effect [qlco]
Observed [ftcn]
